Stock Quotes & Company News | Reuters.com
Edition:
United States

People: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,482.00GBp
24 Jun 2016
Change (% chg)

53.00p (+3.71%)
Prev Close
1,429.00p
Open
1,397.50p
Day's High
1,500.00p
Day's Low
1,363.00p
Volume
30,821,968
Avg. Vol
8,417,170
52-wk High
1,532.10p
52-wk Low
1,210.27p

Elsenhans, Lynn 

Ms. Lynn Laverty Elsenhans is an Independent Non-Executive Director of GlaxoSmithKline Plc., since 1 July 2012. She has a wealth of experience of running a global business and significant knowledge of the global markets in which GSK operates. She served as Chair, President and Chief Executive Officer of Sunoco Inc from 2009 to 2012. Prior to joining Sunoco in 2008 as President and Chief Executive Officer, Lynn worked for Royal Dutch Shell which she joined in 1980 and where she held a number of senior roles, including Executive Vice President, Global Manufacturing from 2005 to 2008. Lynn is a Non-Executive Director of Baker Hughes Inc, a director of the Texas Medical Center, and a director of The First Tee of Greater Houston. She is also a Trustee of the United Way of Greater Houston and a Trustee of Rice University.

Basic Compensation

Total Annual Compensation, GBP 123,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP 90,000
Fiscal Year Total, GBP 213,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --